pseudomonas aeruginosa infection
Showing 1 - 8 of 8
Bronchiectasis Adult, Pseudomonas Aeruginosa Infection Trial in China (Tobramycin Inhalant Product, Ciprofloxacin 750 MG, Oral
Recruiting
- Bronchiectasis Adult
- Pseudomonas Aeruginosa Infection
- Tobramycin Inhalant Product
- +3 more
-
Shanghai, Shanghai, China
- +59 more
Oct 16, 2023
Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection Trial in Jerusalem, Tel Aviv (TP-102)
Recruiting
- Diabetic Foot Ulcer
- +3 more
- TP-102
-
Jerusalem, Israel
- +1 more
Jun 17, 2022
Covid19, Bacteremia, Septicemia Trial (Phage Therapy)
No longer available
- Covid19
- +5 more
- Phage Therapy
- (no location specified)
Dec 6, 2021
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation, Pseudomonas Aeruginosa Infection Trial in United States
Completed
- Cystic Fibrosis
- +2 more
-
Hartford, Connecticut
- +3 more
Jul 27, 2020
Pseudomonas Aeruginosa Infection Trial in Worldwide (Liposomal amikacin for inhalation (Arikayce™) using the PARI
Completed
- Pseudomonas Aeruginosa Infection
- Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.
- Tobramycin inhalation solution using a PARI LC® Plus nebulizer.
-
Vienna, Austria
- +61 more
May 28, 2020
Pseudomonas Aeruginosa Infection Trial in Worldwide (IC43, Placebo)
Completed
- Pseudomonas Aeruginosa Infection
- IC43
- Placebo
-
Graz, Austria
- +49 more
Mar 29, 2016
Pseudomonas Aeruginosa Infection Trial in Seville (Piperacillin-Tazobactam continuous infusion, Piperacillin-Tazobactam
Completed
- Pseudomonas Aeruginosa Infection
- Piperacillin-Tazobactam continuous infusion
- Piperacillin-Tazobactam intermittent infusion
-
Seville, SpainHospital Universitario Virgen del Rocío
Sep 19, 2014